iShares China Large-Cap ETF (FXI)
| Assets | $5.25B |
| NAV | $30.14 |
| Expense Ratio | 0.74% |
| PE Ratio | 10.25 |
| Shares Out | 174.30M |
| Dividend (ttm) | $0.58 |
| Dividend Yield | 1.94% |
| Ex-Dividend Date | Jun 9, 2022 |
| 1-Year Return | -26.99% |
| Volume | 981,997 |
| Open | 29.99 |
| Previous Close | 30.14 |
| Day's Range | 29.72 - 29.89 |
| 52-Week Low | 26.13 |
| 52-Week High | 42.70 |
| Beta | 0.48 |
| Holdings | 57 |
| Inception Date | Oct 5, 2004 |
About FXI
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Top 10 Holdings
56.62% of assets| Name | Symbol | Weight |
|---|---|---|
| MEITUAN | 3690.HK | 8.97% |
| ALIBABA GROUP HOLDING LTD | 9988.HK | 8.17% |
| TENCENT HOLDINGS LTD | 700.HK | 7.69% |
| JD.COM CLASS A INC | 9618.HK | 6.45% |
| CHINA CONSTRUCTION BANK CORP H | 939.HK | 4.90% |
| INDUSTRIAL AND COMMERCIAL BANK OF | 1398.HK | 4.47% |
| BAIDU CLASS A INC | 9888.HK | 4.34% |
| WUXI BIOLOGICS CAYMAN INC | 2269.HK | 4.02% |
| PING AN INSURANCE (GROUP) CO OF CH | 2318.HK | 3.97% |
| BYD LTD H | BY6.DE | 3.63% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 9, 2022 | $0.14593 | Jun 15, 2022 |
| Dec 13, 2021 | $0.4343 | Dec 17, 2021 |
| Jun 10, 2021 | $0.15102 | Jun 16, 2021 |
| Dec 14, 2020 | $0.68357 | Dec 18, 2020 |
| Jun 15, 2020 | $0.33324 | Jun 19, 2020 |
| Dec 16, 2019 | $0.78831 | Dec 20, 2019 |
News
MSA Capital's Ben Harburg on China tech stock plunge: Consumption is down
Ben Harburg, MSA Capital managing partner, joins ‘Squawk on the Street' to discuss the china tech stock plunge in July, marking its worst month of the year.
Chinese stocks have the greatest opportunity for immediate upside, says MSA's Ben Harburg
Ben Harburg, MSA Capital managing partner, joins 'Squawk on the Street' to discuss how the Chinese investing picture looks, what will steady investing nerves in Chinese tech and the long-term investing ...
Options traders making moves in these three stocks
"Halftime Report" trader Pete Najarian spots unusual activity in the options market
3 Chinese Stocks to Buy as DIDI Soars: BABA, FXI, EEM
Didi Global shares are soaring after regulators finally end security probe. Here are three ways to profit from a recovery in Chinese stocks.
Biden was trying to signal that U.S. commitments mean something, says Longview's McNeal
Dewardric McNeal, Longview Global senior policy analyst, joins 'The Exchange' to discuss Biden's remarks about defending Taiwan militarily against China.
If reliant on Chinese goods or services, have a backup, says Longview's Dewardric McNeal
Dewardric McNeal, Longview Global senior policy analyst, joins 'The Exchange' to discuss Biden's remarks about defending Taiwan militarily against China.
Is The Chinese Market's Rebound Over?
After a crash and a significant rebound, it looks like the Chinese stocks may be heading lower once again. As you can see on the following chart, shares of the iShares China Large-Cap ETF (NYSE: FXI) ap...
Is The Chinese Stock Market Rebound Ending?
The rebound in the Chinese stock market could be coming to an end. As you can see on the following charts, the iShares China Large-Cap ETF (NYSE: FXI) is close to a possible resistance level.
China ETFs Are Enjoying One of Their Best Days Ever
China country-specific exchange traded funds surged as Beijing pledges to support the financial markets and Chinese regulators set out to communicate with their U.S. counterparts to reach an agreement o...
China ETFs Jump On Government Support Vow
A key Chinese government committee is promising financial stability in Q1.
2 ETFs to Watch for Outsized Volume on China and Commodity
FXI and USCI saw massive trading volumes in yesterday session.
What's behind the significant declines in Chinese tech stocks?
Cyrus Mewawalla of GlobalData and Ben Harburg of MSA Capital discuss what's been driving the dramatic tumble in many Chinese tech stocks of late, including regulatory and delisting fears.
U.S.-listed China stocks fall on COVID surge, Russia
Chinese companies listed in New York fell sharply during premarket trade on Tuesday after surging COVID-19 cases fuelled fears for the world's second-largest economy and sent mainland firms listed in Ho...
China ETFs Can't Catch a Break
China country-specific exchange traded funds plunged on Monday on growing concerns over Beijing's ties to Russia, risk of U.S. delistings, and another round of lockdown measures to contain its worst COV...
China ETFs Retreat on Threats of U.S. Exchange Delistings
China country-specific exchange traded funds plunged Thursday, with those tracking America depository receipts taking the brunt of the hit, on delisting concerns coming out as the Securities and Exchang...
After a Painful 2021, Is It Time to Buy China ETFs?
Investment banks like Credit Suisse, BlackRock, HSBC, UBS and Goldman Sachs are suggesting the China investing as a buy due to decent inflation, chances of easy money policy, chances of muted regulatory...
Emerging Market ETFs Are Doing Better
Despite a volatile start to 2022, emerging market-related exchange traded funds are outperforming U.S. equities. The iShares MSCI Emerging Markets ETF (EEM) is up 0.6% year-to-date.
Investors Should Take a Look at China ETFs
While the U.S. is tackling slowing growth, elevated inflation, and the ongoing COVID-19 pandemic, investors could be looking to overseas opportunities in China country-specific exchange traded funds. Af...
China ETFs Set to Surge in 2022
China stocks have lately started to build up positive momentum as the rounds of positive news have renewed investors' enthusiasm.
Cathie Wood and China — ETF experts on whether these underperformers could make a 2022 comeback
Cathie Wood's Ark Invest and Chinese stocks were two 2021 underperformers, but they could present a buying opportunity.